AI-Fueled Rebirth Of Forgotten Tech Sectors
As AI accelerates from labs to everyday applications, venture capital is rewriting where money flows. The latest early-stage signals point to a revival of tech sectors that had drifted from the center of the funding universe: healthtech, cybersecurity, biotech, and enterprise SaaS. The trend sits at the intersection of AI-native startups and real-world delivery, a combination that caught the eye of the world’s top 15 venture firms tracked by PitchBook’s Emerging Tech Indicator (ETI).
Q4 2025: A Turning Point For Healthtech And Beyond
New data from the ETI show a decisive uptick in late-2025 activity, with healthtech leading the charge. The health and wellness segment posted $678 million in Q4 across 23 deals, more than doubling the prior eight-quarter average of $332 million and 16 deals. The money is flowing into two core lanes: consumer-oriented platforms that help people track and optimize their bodies, and AI tools that streamline health providers’ operations.
Healthtech: Consumer Platforms And AI-Driven Care
Two notable deals illustrate the breadth of the revival. Function Health, a subscription service offering a wide slate of lab tests and personalized insights, closed a $300 million Series B at a $2.5 billion valuation—an 11.5x uplift from its June 2024 Series A. On the enterprise side, Paradigm Health secured $78 million to expand clinical trial management software, while Valerie Health raised $30 million to automate front-office workflows with AI.
- Function Health: $300 million Series B; valuation $2.5 billion
- Paradigm Health: $78 million for clinical trial management software
- Valerie Health: $30 million to automate front-office workflows with AI
AI-Enabled Care Infrastructure Gets A Boost
Investors are also returning to brick-and-mortar care models when AI augments them rather than trying to replace traditional delivery. Radial Health, a network of mental-health clinics, closed a $50 million Series A, while Knownwell, an obesity-care platform, raised $26.1 million. Together, these deals reflect a shift away from pure telehealth bets toward “AI plus services” that plug into current care delivery systems rather than displacing them.
Cybersecurity Joins The AI-Fueled Rally
Beyond healthtech, cybersecurity reached a new crest in Q4, with total deals worth $643.1 million across 15 transactions. Average deal valuations in the segment climbed to $273.4 million, more than double the eight-quarter average of $129.1 million. The surge was heavily weighted toward Series A rounds, underscoring the maturation and bold bets in AI-enabled security tooling.
- Cybersecurity Q4 total: $643.1 million across 15 deals
- Average cybersecurity deal valuation: $273.4 million
- Share of deals in Series A rounds: majority of the 15
What Is Driving The Shift? There Is A Clear AI Anchor
Industry insiders point to AI’s practical impact on unit economics, risk management, and operational efficiency as the catalyst for reviving tech sectors that were briefly overlooked. The ETI notes that AI-native startups now appear in every tier from pre-seed to Series B, and they often pursue models that combine data-driven services with hands-on, real-world delivery. Analysts say this blend can create durable demand and predictable revenue cycles, even in markets that look high-risk on the surface.
“The AI signal isn’t just about new models; it’s about how these tools can be deployed to improve margins and outcomes in sectors like health and security,” said Lina Chen, a partner at NorthBridge Ventures. “Investors aren’t chasing hype; they’re chasing paths to repeatable units and long-term cash flow.”
Reviving Tech Sectors That The Market Had Put In The Periphery
One striking element of the current cycle is the focus on reviving tech sectors that the market had previously deprioritized. The phrase reviving tech sectors that points to a broader appetite for AI-enabled businesses that pair sophisticated software with essential services or infrastructure. This stance aligns with a growing belief among top funds that AI can unlock efficiency, data insights, and new value in established industries rather than just spawning novelty products.
For investors, the implications extend beyond venture rounds. Public market participants and retirement savers looking for exposure to high-growth tech themes may see indirect channels through which AI-led innovation affects valuations, corporate earnings, and the competitive dynamics among software and tech-enabled service providers.
What This Means For Personal Finance In 2026
While private market investing remains mostly out of reach for the average saver, the AI-driven revival of these tech sectors is shaping the broader market narrative and influencing public equities and ETF strategies. Here’s what personal finance watchers should note:
- Public AI leaders gain a new halo as private rounds back AI-first healthtech, security, and biotech players.
- AI-enabled enterprise software may improve profit visibility for firms that scale efficiently, potentially supporting higher multiples in selected stocks.
- Private-market signals sometimes filter into public markets as venture-backed firms explore IPOs or strategic transactions in 12-36 months, affecting near-term volatility and sector rotations.
Experts caution that this wave does not guarantee immediate wealth or safe bets for every investor. The quality of execution, margins, and regulatory factors will determine which AI-enabled ventures translate venture dollars into sustainable profits. Still, the current push signals a broader adoption of AI across traditional industries, with implications for long-run returns and risk management in diversified portfolios.
A Data Snapshot From The ETI Window
The PitchBook Emerging Tech Indicator continues to track the activity of the world’s top venture firms, offering a lens on where money is migrating. Here are the season’s headline figures that accompany the broader trend:
- Healthtech Q4 2025: $678 million across 23 deals
- Eight-quarter healthtech average: $332 million across 16 deals
- Function Health Series B: $300 million at a $2.5 billion valuation
- Paradigm Health Series: $78 million for clinical trial management software
- Valerie Health Series: $30 million to automate front-office AI workflows
- Radial Health Series A: $50 million
- Knownwell Series: $26.1 million
- Cybersecurity Q4 2025: $643.1 million across 15 deals
- Cybersecurity average deal: $273.4 million
- Share of Q4 deals that were Series A: majority of the cybersecurity tranche
Looking Ahead: Cautious Optimism And Practical Bets
Analysts expect the AI-enabled revival to persist into 2026, albeit with the usual emphasis on disciplined capital deployment and clear unit economics. Firms that can demonstrate scalable AI-enabled services and real-world outcomes are likelier to attract follow-on rounds at healthier valuations. For personal finance enthusiasts, the story is less about chasing the hottest brand name and more about watching for durable advantages that AI can deliver in sectors with tangible needs and established channels of care and security.
In the near term, investors should stay alert for:
- Public companies deploying AI to optimize health services or security operations
- New AI-enabled platforms that show measurable cost savings or health outcomes
- IPO readiness signals from venture-backed firms pursuing profitable, scalable models
Bottom Line
The AI wave is reshaping venture priorities in ways that could influence personal finance longer term. The data from Q4 2025 shows a clear pivot toward reviving tech sectors that blend AI power with practical delivery, moving beyond hype toward assets with real-world utility. For investors, the challenge remains: separate the durable builders from the flashy experiments and stay focused on risk-adjusted returns as this new cycle unfolds.
Discussion